Diagnostic Consulting Center 1 Sliven EOOD

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• COPD2 trials
• Psoriasis2 trials
• Asthma1 trial
• Psoriatic arthritis1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Active, not recruiting3 trials
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• Areteia Therapeutics Inc.1 trial
• Can-Fite BioPharma1 trial
• Janssen Research & Development, LLC1 trial
• UCB Biopharma SRL1 trial
• Upstream Bio Inc.1 trial

Running trials

• Recruiting

  A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis

  NCT07725939· Phase 2· UCB Biopharma SRL· Source

• Active, not recruiting

  A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD

  NCT06981078· Phase 2· Upstream Bio Inc.· Source

• Not yet recruiting

  A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy

  NCT06643260· Phase 3· Can-Fite BioPharma· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis

  NCT06807424· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Completed

  A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-2)

  2023-507665-25-00· Phase 3· Areteia Therapeutics Inc.· Source